The Federation of Indian Chambers of Commerce & Industry (FICCI) has launched the ‘Bharat Life Sciences Awards’, a first-of-its-kind national institutional platform to recognise excellence in life sciences research, capability, and public health impact in India, in partnership with Eli Lilly and Company (India).

Conceived as a rigorous, independent, and enduring platform, the awards are anchored in a shared national vision for Viksit Bharat, recognising that sustained progress in health is driven by a sustained commitment to innovation.

This initiative convened in consultation with the Office of the Principal Scientific Adviser to the Government of India and the Department of Pharmaceuticals (DoP), with the Biotechnology Industry Research Assistance Council (BIRAC) and Invest India, will bring together a unique ecosystem of innovators, researchers, and institutions across the life sciences sector.

The inaugural Bharat Life Sciences Awards ceremony will be held on 1st October 2026, marking a defining moment in recognising and celebrating India’s scientific excellence.

The Bharat Life Sciences Awards will be governed by an eminent Advisory Council and adjudicated by an independent jury of experts in life sciences, innovation, and public health. Grant Thornton Bharat will serve as the Process Advisor, reinforcing the platform’s commitment to transparency, credibility, and integrity at every stage.

Dr. Jitendra Kumar, Managing Director, Biotechnology Industry Research Assistance Council (BIRAC) said, “Platforms such as the Bharat Life Sciences Awards can play a valuable role in bringing together stakeholders across this ecosystem, recognising excellence and supporting the translation of science into solutions for public health.”

Jyoti Vij, Director General, FICCI said, “Through this initiative, FICCI is proud to partner with stakeholders across the ecosystem to further strengthen India’s position as a global hub for life sciences research, innovation, and healthcare solutions.”

“India’s life sciences ecosystem is reaching a new level of scientific maturity, with the talent, institutions, and ambition to contribute meaningfully to global health,” said Winselow Tucker, President and General Manager, Eli Lilly and Company (India).